Moelis
MC · NYSE
About MC
- Employees
- 1,416
- Headquarters
- New York City, New York
- Listed
- Apr 16, 2014
- Sector
- Financials
- Industry
- Capital Markets
- Website
- moelis.com
MC key statistics
- Market cap
- 4.37B
- Price-earnings ratio
- 18.49
- Dividend yield
- 5.05%
- Average volume
- 1.02M
- Volume
- 1.05M
- Open price
- $53.06
- High today
- $55.06
- Low today
- $52.71
- 52 Week high
- $78.22
- 52 Week low
- $51.06
Moelis (MC) at a glance
As of Oct 20, 2026, Moelis (MC) shares are priced at $53.85, giving the company a market cap of 4.37B, a price-to-earnings ratio of 18.49 and a dividend yield of 5.05%.
Today the stock has traded between $52.71 and $55.06. The current price is 2.2% above the day's low and 2.2% below its high.
Volume so far is 1.05M shares, in line with the average of 1.02M shares a day.
Over the past year Moelis has ranged from $51.06 to $78.22, and now sits 10% of the way up that range.
Moelis met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.63 per share against an estimate of $0.6376.
The average analyst price target is $72.99, 35.5% above the current price, from 6 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy33.3%
- Hold66.7%
- Sell0.0%
- Low
- $60.60
- Now
- $53.85
- High
- $90.30
MC earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 39.8% on average.
- Q3 FY24: reported $0.22 per share against an estimate of $0.2161
- Q4 FY24: reported $1.18 per share against an estimate of $0.4996
- Q1 FY25: reported $0.64 per share against an estimate of $0.5719
- Q2 FY25: reported $0.53 per share against an estimate of $0.376
- Q3 FY25: reported $0.67 per share against an estimate of $0.5874
- Q4 FY25: reported $1.13 per share against an estimate of $0.8426
- Q1 FY26: reported $0.50 per share against an estimate of $0.5651
- Q2 FY26: reported $0.63 per share against an estimate of $0.6376
MC news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Moelis & Company Reports Second Quarter and First Half 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share
- Press releaseBusiness Wire
Moelis & Company to Announce Second Quarter 2026 Financial Results and Host a Conference Call on July 29, 2026
- Press releaseBusiness Wire
Moelis CEO Navid Mahmoodzadegan to Speak at the 2026 Morgan Stanley US Financials Conference
'Seattle's Holloway Hires JPMorgan, Moelis for NBA Expansion Bid' - Bloomberg
- Press releaseBusiness Wire
Moelis & Company Reports First Quarter 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share
- Press releaseBusiness Wire
Moelis & Company to Announce First Quarter 2026 Financial Results and Host a Conference Call on April 29, 2026
- Press releasePRNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Moelis & Company (NYSE: MC)
Similar companies
Companies in the same industry as Moelis
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.